Live Breaking News & Updates on Its Selective Inhibitor Of Nuclear Export

Stay updated with breaking news from Its selective inhibitor of nuclear export. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Receives $9.43 Average Target Price from Brokerages

Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Rating) have been assigned a consensus recommendation of “Moderate Buy” from the eight ratings firms that are currently covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The […] ....

Piper Sandler , Richarda Paulson , Michael Mason , Karyopharm Therapeutics Inc , Advisor Group Holdings Inc , Nisa Investment Advisors , Mercer Global Advisors Inc , Its Selective Inhibitor Of Nuclear Export , Morgan Stanley , Life Insurance Co , Janney Montgomery Scott , Karyopharm Therapeutics , Get Rating , Marketbeat Ratings , Investment Advisors , Group Holdings , Montgomery Scott , Mercer Global Advisors , Selective Inhibitor , Nuclear Export , Karyopharm Therapeutics Daily , Nasdaq Kpti ,

Redwood Wealth Management Group LLC Purchases New Shares in Karyopharm Therapeutics Inc. (NASDAQ:KPTI)

Redwood Wealth Management Group LLC acquired a new position in shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Rating) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 33,230 shares of the company’s stock, valued at approximately $113,000. Other hedge funds and other […] ....

United States , Piper Sandler , Michael Mason , Richarda Paulson , Balyasny Asset Management , Vanguard Group Inc , Redwood Wealth Management Group , Morgan Stanley , Securities Exchange Commission , Its Selective Inhibitor Of Nuclear Export , Karyopharm Therapeutics Inc , America Corp , Karyopharm Therapeutics , Get Rating , Street Corp , Point Capital Management , Asset Management , Selective Inhibitor , Nuclear Export , Karyopharm Therapeutics Daily , Nasdaq Kpti , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Richard A. Paulson Sells 3,497 Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Stock

Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Rating) CEO Richard A. Paulson sold 3,497 shares of the company’s stock in a transaction dated Tuesday, April 4th. The stock was sold at an average price of $3.97, for a total transaction of $13,883.09. Following the completion of the transaction, the chief executive officer now owns 816,619 shares […] ....

Richarda Paulson , Piper Sandler , Prelude Capital Management , Janney Montgomery Scott , Nisa Investment Advisors , Its Selective Inhibitor Of Nuclear Export , Morgan Stanley , Karyopharm Therapeutics Inc , Life Insurance Co , Advisor Group Holdings Inc , Karyopharm Therapeutics , Get Rating , Investment Advisors , Group Holdings , Montgomery Scott , Selective Inhibitor , Nuclear Export , Karyopharm Therapeutics Daily , Nasdaq Kpti , Insider Trading , Nsider Trades ,

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Sees Large Decline in Short Interest

Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Rating) was the recipient of a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 16,730,000 shares, a decline of 8.7% from the February 28th total of 18,330,000 shares. Based on an average daily volume of 2,760,000 shares, the […] ....

Los Angeles , United States , Sohanya Roshan Cheng , Michael Mason , Piper Sandler , Its Selective Inhibitor Of Nuclear Export , Karyopharm Therapeutics Inc , Caxton Associates , Los Angeles Capital Management , Karyopharm Therapeutics Company Profile , Morgan Stanley , Securities Exchange Commission , Karyopharm Therapeutics , Get Rating , Exchange Commission , Roshan Cheng , Angeles Capital Management , Retirement System , Capital Management , Exoduspoint Capital Management , Point Capital Management , Selective Inhibitor , Nuclear Export , Karyopharm Therapeutics Daily , Nasdaq Kpti ,

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Short Interest Update

Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Rating) was the target of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 16,730,000 shares, a decline of 8.7% from the February 28th total of 18,330,000 shares. Based on an average daily trading volume, of 2,760,000 shares, […] ....

Piper Sandler , Sohanya Roshan Cheng , Michael Mason , Its Selective Inhibitor Of Nuclear Export , Karyopharm Therapeutics Inc , Nisa Investment Advisors , Mackenzie Financial Corp , Life Insurance Co , Advisor Group Holdings Inc , Northern Trust Corp , Morgan Stanley , Securities Exchange Commission , Karyopharm Therapeutics , Get Rating , Roshan Cheng , Exchange Commission , Financial Corp , Trust Corp , Investment Advisors , Advisor Group Holdings , Group Holdings , Selective Inhibitor , Nuclear Export , Karyopharm Therapeutics Daily , Nasdaq Kpti ,